Compare ARK Genomic Revolution ETF (ARKG) vs IONQ Inc (IONQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs IONQ Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while IONQ Inc trades at $42.13 (market cap $16.00B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | IONQ | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $82.09 |
52-Week Low | $23.09 | $26.59 |
Market Cap | — | $16.00B |
Enterprise Value | — | $14.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IONQ trades at $42.86, down 4.27% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported strong revenue growth with 2025 revenue of $130.02M and a net loss of $510.38M, though profitability is projected for 2026. Recent earnings beats in Q4 2025 and Q1 2026 contrast with a Q3 2025 miss, while analyst consensus is split evenly between Buy and Hold ratings.
Outlook remains speculative with high valuation multiples (P/E 109.9, P/S 72.37) reflecting growth expectations in quantum computing. Key risks include cash burn and competitive pressures, but institutional sentiment is supported by a $73.75 price target and strong liquidity position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →
